Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
Status:
Completed
Trial end date:
2015-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to determine whether Maraviroc is effective in the
treatment of Kaposi's Sarcoma (KS), when it does not remit with standard antiretroviral drug
therapy.